GlassScriptPhysician profile
Fang Rong Wang
NPI 1558386078
$3,798.34
in general payments reported to CMS, 2019-2025
22 companies · $1,552 in 2025
The $1,552 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $384 · 2021: $119 · 2022: $355 · 2023: $303 · 2024: $44.52 · 2025: $1,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $831.87 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $520.17 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Kowa Pharmaceuticals America, INC. | $246.81 | 2022-2025 | Zoryve |
| Cequr Corporation | $232.97 | 2023 | Cequr Simplicity |
| Allergan, INC. | $224.76 | 2019-2020 | |
| Amarin Pharma, INC. | $142.59 | 2019 | |
| Phathom Pharmaceuticals, INC. | $140.00 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $140.00 | 2025 | |
| Vivus LLC | $125.00 | 2025 | Pancreaze |
| Eisai INC. | $125.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2025 | Rexulti |
| Aimmune Therapeutics, INC. | $124.99 | 2025 | Zenpep |
| Pfizer INC. | $124.98 | 2025 | |
| Axsome Therapeutics, INC. | $124.98 | 2025 | Symbravo |
| Glaxosmithkline, LLC. | $124.03 | 2025 | Arexvy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $121.27 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.63 | 2025 | Xifaxan |
| Abbott Laboratories | $78.52 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.42 | 2021 | |
| Radius Health, INC. | $35.00 | 2019 | |
| Nestle Healthcare Nutrition INC. | $24.75 | 2021 | |
| Merck Sharp & Dohme LLC | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fang Rong Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.